ROSC
Hartford Multifactor Small Cap ETF
ROSC tracks a rules-based index designed to provide exposure to small cap equities with less volatility than traditional cap-weighted indices.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 48.4 M
ASSETS UNDER MGMT
34 bp
EXPENSES
Fund Basics
| Inception date | Mar 24, 2015 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Semi-annual |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| ONESPAN INC. | 1.4 % |
| CRANE HOLDINGS, CO. | 1.3 % |
| CAREER EDUCATION CORP | 1.2 % |
| HAEMONETICS CORP/MASS | 1.1 % |
| MEDNAX INC | 1.1 % |
| TERADATA CORP | 1.0 % |
| IDT CORPORATION CLASS B | 1.0 % |
| INDIVIOR PHARMACEUTICALS INC ORDINARY SH | 1.0 % |
| ORGANON & CO. | 1.0 % |
| EPLUS INC | 1.0 % |
Constituent Breakdown
| Number of holdings | 316 |
| Herfindahl-Hirschman Index | 52 |
| Wgt avg mkt cap (mns) | $2,287 |
| Large cap (>$10bn) | 1.5% |
| Mid cap ($2-10bn) | 47.5% |
| Small cap (<$2bn) | 47.0% |
| Developed mkts. | 95.8% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 92.0 % |
 |
BERMUDA | 1.7 % |
 |
PUERTO RICO | 0.9 % |
 |
CANADA | 0.6 % |
 |
NETHERLANDS | 0.6 % |
Historical Performance
Standardized Performance (as of 09/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 13.9% | 17.7% | 10.6% | 14.1% | 7.0% | 7.6% | -- | 6.8% |
| Dividend Yield | 1.5% | 2.5% | 2.4% | 2.4% | 2.3% | 2.5% | -- | 2.5% |
| Total Returns | 15.4% | 20.2% | 13.0% | 16.5% | 9.4% | 10.1% | -- | 9.2% | Ann. Volatility | 13.5% | 13.9% | 17.7% | 18.0% | 19.1% | 20.2% | -- | 19.8% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.66 | 38% |
| MSCI EAFE | 0.53 | 36% |
| MSCI Emg Mkts | 0.24 | 19% |
Liquidity Measures
| Avg. volume (000) | 2 |
| ADV traded (mns) | $0 |
| Turnover | 0.2% |
| Avg. Bid/Ask (% of price) | 0.39% |
Technical Indicators
| 30d moving avg. (EMA) | $54.92 |
| Relative strength (RSI) | 53 |
| MACD/Signal | 0.31/0.23 |
| Bollinger Bands (Upper/Lower) | $56.11/$53.68 |
| Short interest (% of AUM) | 0.1% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. ROSC |
Expenses vs. ROSC |
ALTAR Score™ vs. ROSC |
|---|---|---|---|---|
| EES | WisdomTree U.S. SmallCap Fund | 30.1% | +4 bp | +0.3% |
| DES | WisdomTree U.S. SmallCap Dividend Fund | 29.2% | +4 bp | -0.2% |
| FYT | First Trust Small Cap Value AlphaDEX Fund | 28.0% | +36 bp | +2.1% |
| BRSV | EA Bridgeway Select Small-Cap Value ETF | 27.3% | +56 bp | -0.5% |
| AFSM | First Trust Active Factor Small Cap ETF | 26.5% | +41 bp | -1.8% |
| SQLV | Royce Quant Small-Cap Quality Value ETF | 26.3% | +26 bp | -0.5% |
| JPSE | JPMorgan Diversified Return U.S. Small Cap Equity ETF | 25.6% | -5 bp | -1.2% |
| SVAL | iShares US Small Cap Value Factor ETF | 24.8% | -14 bp | 0.0% |
| FYX | First Trust Small Cap Core AlphaDEX Fund | 24.3% | +24 bp | -2.4% |
| SMLV | State Street SPDR US Small Cap Low Volatility Index ETF | 24.1% | -22 bp | -4.0% |
Risk and Returns: ROSC vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 11/6/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
8.6%
ALTAR SCORE™
92nd
PERCENTILE
SPECULATIVE
ETFRC RATING
There are 1,388 funds in the US Equity category with an average
ALTAR Score™ of 5.7% and a standard deviation
of 2.1%. ROSC's ALTAR Score™ is approximately 1.4 standard
deviations above the category average. This places ROSC in the 92nd percentile
among funds in the category.
Sell-Side Consensus
$65.26
PRICE TARGET
+19.8%
UPSIDE